MedPath

The effect of the Ghors-e-Vard” ?on functional dyspepsia

Phase 3
Conditions
Functional dyspepsia.
Registration Number
IRCT20200128046291N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients with Functional dyspepsia
Ages 18 to 65 years

Exclusion Criteria

History of gastrointestinal ulcer or reflux disease with natural endoscopy with no specific pathologic findings,
Underlying diseases including heart failure, hypertension, renal failure and uremic disease, cirrhosis
History of abdominal surgery
Any malignancy
NSAIDs Use
Having a history of chemotherapy and radiotherapy or exposure to radioactive radiation.
Use of any other herbal medicine
Pregnancy and lactation
Positive urea breath test for Helicobacter pylori infection

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in clinical symptoms of functional dyspepcia. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).
Secondary Outcome Measures
NameTimeMethod
Epigastric pain. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Heart burn. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Early satiety. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Feeling fullness after meals. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Nausea. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Burp. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Flatulence. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale(GSRS).;Quality of Life. Timepoint: In days 0,30. Method of measurement: Quality of Life Questionnaire (SF36).
© Copyright 2025. All Rights Reserved by MedPath